Skip to main content

Table 1 Relationship between the expressions of VEGFR2 and VTN with clinicopathological features

From: VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer

Clinicopathologic features

No.

VEGFR2 expression

VTN expression

High (No.)

Low (No.)

χ2

P value

High (No.)

Low (No.)

χ2

P value

Gender

 

96

60

  

92

64

  

 Men

110

65

45

0.944

0.331

62

48

1.051

0.305

 Women

46

31

15

30

16

Age (years)

 <65

90

53

37

0.631

0.427

51

39

0.468

0.494

 ≥65

66

43

23

41

25

Tumor size (cm)

 <5

101

58

43

2.047

0.153

55

46

2.418

0.12

 ≥5

55

38

17

37

18

Lauren type

 Intestinal type

91

55

36

0.111

0.739

53

38

0.048

0.826

 Diffuse type

65

41

24

39

26

Degree of differentiation

 Highly

46

28

18

0.012

0.912

26

20

0.162

0.687

 Moderately and Poorly

110

68

42

66

44

Depth of invasion

 T1, T2

61

28

33

10.348

<0.001**

27

34

8.961

<0.003**

 T3, T4

95

68

27

65

30

Lymphonodus metastasis

 N0, N1

50

22

28

9.563

<0.002**

21

29

8.763

<0.003**

 N2, N3

106

74

32

71

35

AJCC stage

 I, II

51

18

33

22.05

<0.001**

18

33

17.561

<0.001**

 III, IV

105

78

27

  

74

31

  
  1. **indicates P<0.01